Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D02KMG
|
||||
| Former ID |
DCL000563
|
||||
| Drug Name |
Milveterol
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Chronic obstructive pulmonary disease; Asthma [ICD9: 490-492, 493, 494-496; ICD10:J40-J44, J47, J45] | Discontinued in Phase 2 | [537130] | ||
| Company |
GSK
|
||||
| Formula |
C25H29N3O4
|
||||
| Canonical SMILES |
C1=CC=C(C=C1)C(CNC2=CC=C(C=C2)CCNCC(C3=CC(=C(C=C3)O)NC=<br />O)O)O
|
||||
| InChI |
1S/C25H29N3O4/c29-17-28-22-14-20(8-11-23(22)30)24(31)15-26-13-12-18-6-9-21(10-7-18)27-16-25(32)19-4-2-1-3-5-19/h1-11,14,17,24-27,30-32H,12-13,15-16H2,(H,28,29)/t24-,25-/m0/s1
|
||||
| InChIKey |
BMKINZUHKYLSKI-DQEYMECFSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Beta-2 adrenergic receptor | Target Info | Agonist | [550963] | |
| NetPath Pathway | TCR Signaling Pathway | ||||
| Pathway Interaction Database | Arf6 trafficking events | ||||
| Arf6 signaling events | |||||
| References | |||||